Aflibercept, but not anti-Scg3 mAb, retards body weight gain in neonatal mice. Anti-Scg3 ML78.2 mAb or aflibercept was i.p. injected to mice at P3, 5, 7, 9, 11 and 13. a Representative images of mouse size. b Body weight of aflibercept-treated mice. c Body weight of anti-Scg3 mAb-treated mice. n=3 mice, ±SEM, one-way ANOVA test.